Exhibit 107

 

Calculation of Filing Fee Tables

 

S-1

(Form Type)

 

ASPIRE BIOPHARMA HOLDINGS, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

   Security
Type		  Security
Class Title		  Fee
Calculation
or Carry
Forward
Rule		  Amount
Registered		  Proposed
Maximum
Offering
Price Per
Unit		   Maximum
Aggregate
Offering
Price (1)(2)		   Fee Rate   Amount of
Registration
Fee (4)		   Carry
Forward
Form
Type		   Carry Forward
File
Number		   Carry
Forward
Initial
Effective
Date		   Filing Fee
Previously
Paid in
Connection
with Unsold
Securities
to be
Carried
Forward		 
Newly Registered Securities 
Fees to be Paid  Equity  Common Stock, $0.0001par value per share  Rule 457(c)   8,327,919   (5)  $2,748,213.27(5)  $0.00015310   $420.75                    
Fees to be Paid  Equity  Common Stock, issuable upon the conversion of the Senior Secured Convertible Debentures  Rule 457(o)   2,929,000  $1.50   $4,393,500.00(5)  $0.00015310   $672.65                     
Fees Previously Paid  —  —  —   —   —    —    —    —                     
Carry Forward Securities                                                     
Carry Forward Securities  —  —  —   —   —    —    —    —    —    —    —    — 
Total Offering Amounts                    $7,141,713.27   $0.00015310   $1,093.40                     
Total Fees Previously Paid                               —                     
Total Fee Offset                               —                     
Net Fee Due                              $1,093.40                     

 

(1) Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended (the “Securities Act”). Represents only the additional number of shares being registered. This does not include the securities that the Registrant previously registered on the Registration Statement on Form S-1.
   
(2) Pursuant to Rule 416(a) under the Securities Act of 1933, this registration statement shall also cover an indeterminate number of shares that may be issued and resold resulting from stock splits, stock dividends or similar transactions.
   
(3) In accordance with Rule 416(a), the Registrant is also registering an indeterminate number of additional shares that shall be issuable pursuant to Rule 416 to prevent dilution resulting from share splits, share dividends or similar transactions.
   
(4) The registration fee is calculated in accordance with Rule 457(a) under the Securities Act of 1933, as amended, or the Securities Act, based on the proposed maximum aggregate offering price.
   
(5) The Price per share used to obtain the maximum offering amount of such Common Stock for the purposes of calculating the registration fee was the average of the high and low trading prices of the Company’s Common Stock reported by Nasdaq on May 12, 2025 ($0.33)